|
|
Continuous thermal reactor system and method
What is claimed is: 1. A continuous thermal reactor comprising a reactor vessel defining an elongated upright reaction chamber having a feed inlet in the upper portion ...
|
|
|
Somatostatin analogs
What is claimed is: 1. The peptides having the structure: ##STR55## wherein: X is CH.sub.2, S, ##STR56## SO.sub.2 and [X].sub.n wherein n=0; Y is CH.sub.2, S, ##STR57## S...
|
|
|
4-Styryl-hexahydro-4-indolinols
I claim: 1. A compound of formula I, ##STR7## wherein R.sub.1 and R.sub.2 are, independently, hydrogen, fluorine, chlorine, trifluoromethyl, alkyl of 1 to 4 carbon atoms,...
|
|
|
Derivatives of 1,3-benzodioxole, the preparation and use thereof
OF THE INVENTION It has been surprisingly found that the compounds of the general formula I are very active for the treatment of heart arrhythmia. Said compounds can be ...
|
|
|
Method of preparing L-(+)-.beta.-hydroxyisobutyric acid by fermentation
OF THE INVENTION The microorganism preferably employed in carrying out the method of the present invention will be Pseudomonas aeruginosa, for example, ATCC #15523 or ...
|
|
|
Six base oligonucleotide linkers and methods for their use
I claim: 1. A method for inserting a selected restriction site into a double stranded genetic sequence at a selected tab site comprising: treating a double stranded DNA ...
|
|
|
Immunoassay with chromatographic medium and labelled reagent
We claim: 1. A method of performing an immunoassay for an analyte in a sample, which method comprises providing a chromatographic medium, forming a reaction mixture ...
|
|
|
Stabilized urease composition
What is claimed is: 1. Stabilized urease composition comprising urease of a specific activity of from 25-1500 U/mg and, as a stabilizing agent, a stabilizing mixture of ...
|
|
|
Stabilized enzymic solutions for determining urea
OF THE INVENTION The stabilized enzyme solutions herein can be used in the clinical field for the determination of urea. The stabilized enzyme solutions herein can be ...
|
|
|
Non-transformed thymidine kinaseless cell line and its use for testing tumorigenic potential of genes
We claim: 1. A method for the determination of the tumorigenic or morphological transforming potential of a non-thymidine kinase (TK) gene comprising, introducing a non-T...
|